Nitrile medical gloves are primarily used in the healthcare and food sectors as a preventative measure to lower the possibility of patients and caregivers acquiring the same infection. Nitrile medical gloves have undergone numerous iterations over the years. Each of the variations has unique benefits over everyday usage gloves. These benefits are excellent strength, longevity, and barrier defense against bloodborne pathogens.
Severe acute respiratory syndrome (SARS), middle east respiratory syndrome (MERS), and the common cold are some coronaviruses that cause human illness. Coronavirus causes mild to severe respiratory illnesses, including fatalities. The best preventive measures are using a mask, avoiding close contact with others, frequently washing your hands, keeping hands away from the face, and getting enough rest and food. As of April 15, 2021, there had been 138,927,001 confirmed coronavirus cases, of which 2,987,914 patients had died. As more people contract COVID-19, healthcare workers will likely need more personal protective equipment. As a result, the global medical nitrile gloves market is anticipated to grow as infection rates rise.
Key players in the current market significantly impact shifting market trends for medical nitrile gloves. Major players are seen making strategic choices, focusing more on collaboration and acquisition to strengthen their product portfolios and expand their science and technology capabilities globally. The appointment of distributors is another way that major players expand their businesses. This has been done to broaden their regional reach and penetrate new markets.
The economic outlook is expected to support recovery in developing countries like Saudi Arabia, the United Arab Emirates, China, Indonesia, Argentina, Brazil, and India. Numerous governments worldwide, including the Ministry of Health (MoH), is allocating a sizable budget and coordinating initiatives for health promotion. The growth in the population significantly impacts the demand for consumables used in diagnosis and treatment. Businesses in developing economies can collaborate with governmental organizations to provide essential goods and lab supplies.
North America is the most significant shareholder in the global medical nitrile gloves market and is expected to grow at a CAGR of 13.16% during the forecast period. North America has a 39.32% market share because of the high number of COVID-19 patients, the high rate of surgical procedures, and the welcoming import policies in the region. Additionally, the market is anticipated to be more profitable because there are not enough regional manufacturers. Manufacturers and new market entrants in numerous industries received the impetus they needed to introduce products and expand the scope of their product portfolios through agreements due to the rise in patients undergoing clinical observation. In addition, businesses like Med PPE Canada Inc., established in March 2020, launched an international ordering system in November 2020. Its product offerings include sanitizers, respirators, nitrile gloves, and disposable masks.
Europe is expected to grow at a CAGR of 14.32% during the forecast period. Europe is anticipated to experience significant growth during the forecast period due to the greater availability of patients and treatment centers. The presence of state-of-the-art medical facilities, rising government initiatives to promote safety standards and find a cure for the rising number of cases, and rising healthcare costs are the main drivers of the market growth for medical nitrile gloves in the area.